{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T01:58:41Z","timestamp":1793411921063,"version":"4.5.0"},"reference-count":50,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T00:00:00Z","timestamp":1484265600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Eye"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1038\/eye.2016.300","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T15:08:01Z","timestamp":1484320081000},"page":"225-231","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Biomarkers for glaucoma: from the lab to the clinic"],"prefix":"10.1038","volume":"31","author":[{"given":"N","family":"Von Thun Und Hohenstein-Blaul","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kunst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Pfeiffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F H","family":"Grus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,13]]},"reference":[{"issue":"1","key":"BFeye2016300_CR1","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1034\/j.1600-0420.2003.00021.x","volume":"81","author":"A Tuulonen","year":"2003","unstructured":"Tuulonen A, Airaksinen PJ, Erola E, Forsman E, Friberg K, Kaila M et al. The Finnish evidence-based guideline for open-angle glaucoma. Acta Ophthalmol Scand 2003; 81 (1): 3\u201318.","journal-title":"Acta Ophthalmol Scand"},{"issue":"5","key":"BFeye2016300_CR2","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1136\/bjo.80.5.389","volume":"80","author":"HA Quigley","year":"1996","unstructured":"Quigley HA . Number of people with glaucoma worldwide. Br J Ophthalmol 1996; 80 (5): 389\u2013393.","journal-title":"Br J Ophthalmol"},{"issue":"6","key":"BFeye2016300_CR3","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1001\/archopht.1994.01090180121046","volume":"112","author":"MC Leske","year":"1994","unstructured":"Leske MC, Connell AM, Schachat AP, Hyman L . The Barbados Eye Study. Prevalence of open angle glaucoma. Arch Ophthalmol 1994; 112 (6): 821\u2013829.","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"BFeye2016300_CR4","doi-asserted-by":"publisher","first-page":"4254","DOI":"10.1167\/iovs.06-0299","volume":"47","author":"AR Rudnicka","year":"2006","unstructured":"Rudnicka AR, Mt-Isa S, Owen CG, Cook DG, Ashby D . Variations in primary open-angle glaucoma prevalence by age, gender, and race: a Bayesian meta-analysis. Invest Ophthalmol Vis Sci 2006; 47 (10): 4254\u20134261.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3 Suppl","key":"BFeye2016300_CR5","doi-asserted-by":"publisher","first-page":"S19","DOI":"10.1016\/j.ajo.2004.04.058","volume":"138","author":"DS Friedman","year":"2004","unstructured":"Friedman DS, Wilson MR, Liebmann JM, Fechtner RD, Weinreb RN . An evidence-based assessment of risk factors for the progression of ocular hypertension and glaucoma. Am J Ophthalmol 2004; 138 (3 Suppl): S19\u2013S31.","journal-title":"Am J Ophthalmol"},{"issue":"2","key":"BFeye2016300_CR6","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1097\/00061198-199704000-00001","volume":"6","author":"MR Wilson","year":"1997","unstructured":"Wilson MR . The myth of '21'. J Glaucoma 1997; 6 (2): 75\u201377.","journal-title":"J Glaucoma"},{"issue":"3","key":"BFeye2016300_CR7","doi-asserted-by":"publisher","first-page":"262","DOI":"10.1136\/bjo.2005.081224","volume":"90","author":"HA Quigley","year":"2006","unstructured":"Quigley HA, Broman AT . The number of people with glaucoma worldwide in 2010 and 2020. Br J Ophthalmol 2006; 90 (3): 262\u2013267.","journal-title":"Br J Ophthalmol"},{"issue":"10","key":"BFeye2016300_CR8","doi-asserted-by":"publisher","first-page":"5071","DOI":"10.1167\/iovs.10-5289","volume":"51","author":"G Tezel","year":"2010","unstructured":"Tezel G, Yang X, Luo C, Kain AD, Powell DW, Kuehn MH et al. Oxidative stress and the regulation of complement activation in human glaucoma. Invest Ophthalmol Vis Sci 2010; 51 (10): 5071\u20135082.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"BFeye2016300_CR9","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1111\/j.1442-9071.2010.02455.x","volume":"39","author":"M Yanagi","year":"2011","unstructured":"Yanagi M, Kawasaki R, Wang JJ, Wong TY, Crowston J, Kiuchi Y . Vascular risk factors in glaucoma: a review. Clin Experiment Ophthalmol 2011; 39 (3): 252\u2013258.","journal-title":"Clin Experiment Ophthalmol"},{"issue":"3","key":"BFeye2016300_CR10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1001\/archopht.1996.01100130295012","volume":"114","author":"EB Dreyer","year":"1996","unstructured":"Dreyer EB, Zurakowski D, Schumer RA, Podos SM, Lipton SA . Elevated glutamate levels in the vitreous body of humans and monkeys with glaucoma. Arch Ophthalmol 1996; 114 (3): 299\u2013305.","journal-title":"Arch Ophthalmol"},{"issue":"Suppl 1","key":"BFeye2016300_CR11","doi-asserted-by":"publisher","first-page":"S129","DOI":"10.1016\/S0039-6257(99)00010-7","volume":"43","author":"AH Neufeld","year":"1999","unstructured":"Neufeld AH . Nitric oxide: a potential mediator of retinal ganglion cell damage in glaucoma. Surv Ophthalmol 1999; 43 (Suppl 1): S129\u2013S135.","journal-title":"Surv Ophthalmol"},{"key":"BFeye2016300_CR12","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.preteyeres.2013.02.003","volume":"36","author":"K Bell","year":"2013","unstructured":"Bell K, Gramlich OW, Von Thun Und Hohenstein-Blaul N, Beck S, Funke S, Wilding C et al. Does autoimmunity play a part in the pathogenesis of glaucoma? Prog Retin Eye Res 2013; 36: 199\u2013216.","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"BFeye2016300_CR13","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1016\/j.exer.2010.08.016","volume":"93","author":"MB Wax","year":"2011","unstructured":"Wax MB . The case for autoimmunity in glaucoma. Exp Eye Res 2011; 93 (2): 187\u2013190.","journal-title":"Exp Eye Res"},{"issue":"1","key":"BFeye2016300_CR14","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1167\/iovs.12-11067","volume":"54","author":"SK Bhattacharya","year":"2013","unstructured":"Bhattacharya SK, Lee RK, Grus FH . Molecular biomarkers in glaucoma. Invest Ophthalmol Vis Sci 2013; 54 (1): 121\u2013131.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"BFeye2016300_CR15","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/archopht.121.1.48","volume":"121","author":"MC Leske","year":"2003","unstructured":"Leske MC, Heijl A, Hussein M, Bengtsson B, Hyman L, Komaroff E . Factors for glaucoma progression and the effect of treatment: the early manifest glaucoma trial. Arch Ophthalmol 2003; 121 (1): 48\u201356.","journal-title":"Arch Ophthalmol"},{"issue":"10","key":"BFeye2016300_CR16","doi-asserted-by":"publisher","first-page":"1268","DOI":"10.1001\/archopht.120.10.1268","volume":"120","author":"A Heijl","year":"2002","unstructured":"Heijl A, Leske MC, Bengtsson B, Hyman L, Hussein M . Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002; 120 (10): 1268\u20131279.","journal-title":"Arch Ophthalmol"},{"issue":"41","key":"BFeye2016300_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3310\/hta11410","volume":"11","author":"JM Burr","year":"2007","unstructured":"Burr JM, Mowatt G, Hernandez R, Siddiqui MA, Cook J, Lourenco T et al. The clinical effectiveness and cost-effectiveness of screening for open angle glaucoma: a systematic review and economic evaluation. Health Technol Assess 2007; 11 (41)iii-iv, ix-x 1\u2013190.","journal-title":"Health Technol Assess"},{"issue":"1","key":"BFeye2016300_CR18","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1016\/S0161-6420(92)32018-4","volume":"99","author":"HA Quigley","year":"1992","unstructured":"Quigley HA, Katz J, Derick RJ, Gilbert D, Sommer A . An evaluation of optic disc and nerve fiber layer examinations in monitoring progression of early glaucoma damage. Ophthalmology 1992; 99 (1): 19\u201328.","journal-title":"Ophthalmology"},{"issue":"5","key":"BFeye2016300_CR19","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/0002-9394(89)90488-1","volume":"107","author":"HA Quigley","year":"1989","unstructured":"Quigley HA, Dunkelberger GR, Green WR . Retinal ganglion cell atrophy correlated with automated perimetry in human eyes with glaucoma. Am J Ophthalmol 1989; 107 (5): 453\u2013464.","journal-title":"Am J Ophthalmol"},{"key":"BFeye2016300_CR20","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1186\/1471-2288-11-54","volume":"11","author":"JM Burr","year":"2011","unstructured":"Burr JM, Campbell MK, Campbell SE, Francis JJ, Greene A, Hernandez R et al. Developing the clinical components of a complex intervention for a glaucoma screening trial: a mixed methods study. BMC Med Res Methodol 2011; 11: 54.","journal-title":"BMC Med Res Methodol"},{"issue":"3","key":"BFeye2016300_CR21","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1067\/mcp.2001.113989","volume":"69","author":"Biomarkers Definitions Working Group","year":"2001","unstructured":"Biomarkers Definitions Working Group. Biomarkers and surrogate endpoints: preferred definitions and conceptual framework. Clin Pharmacol Ther 2001; 69 (3): 89\u201395.","journal-title":"Clin Pharmacol Ther"},{"key":"BFeye2016300_CR22","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1016\/j.preteyeres.2014.06.004","volume":"42","author":"S Thanos","year":"2014","unstructured":"Thanos S, Bohm MR, Meyer zu Horste M, Prokosch-Willing V, Hennig M, Bauer D et al. Role of crystallins in ocular neuroprotection and axonal regeneration. Prog Retin Eye Res 2014; 42: 145\u2013161.","journal-title":"Prog Retin Eye Res"},{"issue":"3","key":"BFeye2016300_CR23","first-page":"517","volume":"39","author":"E Lutjen-Drecoll","year":"1998","unstructured":"Lutjen-Drecoll E, May CA, Polansky JR, Johnson DH, Bloemendal H, Nguyen TD . Localization of the stress proteins alpha B-crystallin and trabecular meshwork inducible glucocorticoid response protein in normal and glaucomatous trabecular meshwork. Invest Ophthalmol Vis Sci 1998; 39 (3): 517\u2013525.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"BFeye2016300_CR24","doi-asserted-by":"publisher","first-page":"4242","DOI":"10.1167\/iovs.11-8902","volume":"53","author":"SC Sacca","year":"2012","unstructured":"Sacca SC, Centofanti M, Izzotti A . New proteins as vascular biomarkers in primary open angle glaucomatous aqueous humor. Invest Ophthalmol Vis Sci 2012; 53 (7): 4242\u20134253.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye2016300_CR25","first-page":"1437","volume":"14","author":"FH Grus","year":"2008","unstructured":"Grus FH, Joachim SC, Sandmann S, Thiel U, Bruns K, Lackner KJ et al. Transthyretin and complex protein pattern in aqueous humor of patients with primary open-angle glaucoma. Mol Vis 2008; 14: 1437\u20131445.","journal-title":"Mol Vis"},{"key":"BFeye2016300_CR26","doi-asserted-by":"publisher","first-page":"29759","DOI":"10.1038\/srep29759","volume":"6","author":"S Funke","year":"2016","unstructured":"Funke S, Perumal N, Beck S, Gabel-Scheurich S, Schmelter C, Teister J et al. Glaucoma related Proteomic Alterations in Human Retina Samples. Sci Rep 2016; 6: 29759.","journal-title":"Sci Rep"},{"issue":"9-10","key":"BFeye2016300_CR27","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1177\/1120672103013009-1003","volume":"13","author":"SC Joachim","year":"2003","unstructured":"Joachim SC, Grus FH, Pfeiffer N . Analysis of autoantibody repertoires in sera of patients with glaucoma. Eur J Ophthalmol 2003; 13 (9-10): 752\u2013758.","journal-title":"Eur J Ophthalmol"},{"key":"BFeye2016300_CR28","first-page":"132","volume":"10","author":"FH Grus","year":"2004","unstructured":"Grus FH, Joachim SC, Hoffmann EM, Pfeiffer N . Complex autoantibody repertoires in patients with glaucoma. Mol Vis 2004; 10: 132\u2013137.","journal-title":"Mol Vis"},{"issue":"4","key":"BFeye2016300_CR29","doi-asserted-by":"publisher","first-page":"573","DOI":"10.1007\/s00417-007-0737-8","volume":"246","author":"SC Joachim","year":"2008","unstructured":"Joachim SC, Reichelt J, Berneiser S, Pfeiffer N, Grus FH . Sera of glaucoma patients show autoantibodies against myelin basic protein and complex autoantibody profiles against human optic nerve antigens. Graefes Arch Clin Exp Ophthalmol 2008; 246 (4): 573\u2013580.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"8","key":"BFeye2016300_CR30","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1007\/s00417-004-1094-5","volume":"243","author":"SC Joachim","year":"2005","unstructured":"Joachim SC, Pfeiffer N, Grus FH . Autoantibodies in patients with glaucoma: a comparison of IgG serum antibodies against retinal, optic nerve, and optic nerve head antigens. Graefes Arch Clin Exp Ophthalmol 2005; 243 (8): 817\u2013823.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"BFeye2016300_CR31","first-page":"1573","volume":"13","author":"SC Joachim","year":"2007","unstructured":"Joachim SC, Wuenschig D, Pfeiffer N, Grus FH . IgG antibody patterns in aqueous humor of patients with primary open angle glaucoma and pseudoexfoliation glaucoma. Mol Vis 2007; 13: 1573\u20131579.","journal-title":"Mol Vis"},{"issue":"3","key":"BFeye2016300_CR32","doi-asserted-by":"publisher","first-page":"968","DOI":"10.1167\/iovs.05-0685","volume":"47","author":"FH Grus","year":"2006","unstructured":"Grus FH, Joachim SC, Bruns K, Lackner KJ, Pfeiffer N, Wax MB . Serum autoantibodies to alpha-fodrin are present in glaucoma patients from Germany and the United States. Invest Ophthalmol Vis Sci 2006; 47 (3): 968\u2013976.","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"BFeye2016300_CR33","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1080\/02713680701375183","volume":"32","author":"SC Joachim","year":"2007","unstructured":"Joachim SC, Bruns K, Lackner K, Pfeiffer N, Grus FH . Antibodies to alphaB-Crystallin, Vimentin, and Heat Shock Protein 70 in Aqueous Humor of patients with Normal Tension Glaucoma and IgG Antibody Patterns Against Retinal Antigen in Aqueous Humor. Curr Eye Res 2007; 32: 501\u2013509.","journal-title":"Curr Eye Res"},{"issue":"10","key":"BFeye2016300_CR34","doi-asserted-by":"publisher","first-page":"900","DOI":"10.3109\/02713683.2010.495829","volume":"35","author":"SC Joachim","year":"2010","unstructured":"Joachim SC, Wax MB, Seidel P, Pfeiffer N, Grus FH . Enhanced characterization of serum autoantibody reactivity following HSP 60 immunization in a rat model of experimental autoimmune glaucoma. Curr Eye Res 2010; 35 (10): 900\u2013908.","journal-title":"Curr Eye Res"},{"issue":"10","key":"BFeye2016300_CR35","doi-asserted-by":"publisher","first-page":"4734","DOI":"10.1167\/iovs.08-3144","volume":"50","author":"SC Joachim","year":"2009","unstructured":"Joachim SC, Grus FH, Kraft D, White-Farrar K, Barnes G, Barbeck M et al. Complex antibody profile changes in an experimental autoimmune glaucoma animal model. Invest Ophthalmol Vis Sci 2009; 50 (10): 4734\u20134742.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"BFeye2016300_CR36","doi-asserted-by":"publisher","first-page":"1009","DOI":"10.1007\/s00417-011-1633-9","volume":"249","author":"OW Gramlich","year":"2011","unstructured":"Gramlich OW, Joachim SC, Gottschling PF, Laspas P, Cuny CS, Pfeiffer N et al. Ophthalmopathology in rats with MBP-induced experimental autoimmune encephalomyelitis. Graefes Arch Clin Exp Ophthalmol 2011; 249 (7): 1009\u20131020.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"12","key":"BFeye2016300_CR37","doi-asserted-by":"publisher","first-page":"8835","DOI":"10.1167\/iovs.10-6889","volume":"52","author":"P Laspas","year":"2011","unstructured":"Laspas P, Gramlich OW, Muller HD, Cuny CS, Gottschling PF, Pfeiffer N et al. Autoreactive antibodies and loss of retinal ganglion cells in rats induced by immunization with ocular antigens. Invest Ophthalmol Vis Sci 2011; 52 (12): 8835\u20138848.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"7","key":"BFeye2016300_CR38","doi-asserted-by":"publisher","first-page":"e40616","DOI":"10.1371\/journal.pone.0040616","volume":"7","author":"SC Joachim","year":"2012","unstructured":"Joachim SC, Gramlich OW, Laspas P, Schmid H, Beck S, von Pein HD et al. Retinal ganglion cell loss is accompanied by antibody depositions and increased levels of microglia after immunization with retinal antigens. PLoS One 2012; 7 (7): e40616.","journal-title":"PLoS One"},{"issue":"2","key":"BFeye2016300_CR39","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1007\/s12031-013-0125-2","volume":"52","author":"SC Joachim","year":"2014","unstructured":"Joachim SC, Mondon C, Gramlich OW, Grus FH, Dick HB . Apoptotic retinal ganglion cell death in an autoimmune glaucoma model is accompanied by antibody depositions. J Mol Neurosci 2014; 52 (2): 216\u2013224.","journal-title":"J Mol Neurosci"},{"issue":"4","key":"BFeye2016300_CR40","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1007\/s12031-015-0707-2","volume":"58","author":"R Noristani","year":"2016","unstructured":"Noristani R, Kuehn S, Stute G, Reinehr S, Stellbogen M, Dick HB et al. Retinal and Optic Nerve Damage is Associated with Early Glial Responses in an Experimental Autoimmune Glaucoma Model. J Mol Neurosci 2016; 58 (4): 470\u2013482.","journal-title":"J Mol Neurosci"},{"issue":"1","key":"BFeye2016300_CR41","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1167\/iovs.13-12714","volume":"55","author":"OW Gramlich","year":"2014","unstructured":"Gramlich OW, Lueckner TC, Kriechbaum M, Teister J, Tao X, von Pein HD et al. Dynamics, alterations, and consequences of minimally invasive intraocular pressure elevation in rats. Invest Ophthalmol Vis Sci 2014; 55 (1): 600\u2013611.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"12","key":"BFeye2016300_CR42","doi-asserted-by":"publisher","first-page":"6431","DOI":"10.1167\/iovs.10-5212","volume":"51","author":"KM Joos","year":"2010","unstructured":"Joos KM, Li C, Sappington RM . Morphometric changes in the rat optic nerve following short-term intermittent elevations in intraocular pressure. Invest Ophthalmol Vis Sci 2010; 51 (12): 6431\u20136440.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"1","key":"BFeye2016300_CR43","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12974-016-0542-6","volume":"13","author":"OW Gramlich","year":"2016","unstructured":"Gramlich OW, Teister J, Neumann M, Tao X, Beck S, von Pein HD et al. Immune response after intermittent minimally invasive intraocular pressure elevations in an experimental animal model of glaucoma. J Neuroinflammation 2016; 13 (1): 82.","journal-title":"J Neuroinflammation"},{"issue":"1","key":"BFeye2016300_CR44","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s12886-015-0044-9","volume":"15","author":"K Bell","year":"2015","unstructured":"Bell K, Wilding C, Funke S, Pfeiffer N, Grus FH . Protective effect of 14-3-3 antibodies on stressed neuroretinal cells via the mitochondrial apoptosis pathway. BMC Ophthalmol 2015; 15 (1): 64.","journal-title":"BMC Ophthalmol"},{"issue":"3","key":"BFeye2016300_CR45","doi-asserted-by":"publisher","first-page":"e90737","DOI":"10.1371\/journal.pone.0090737","volume":"9","author":"C Wilding","year":"2014","unstructured":"Wilding C, Bell K, Beck S, Funke S, Pfeiffer N, Grus FH . Gamma-synuclein antibodies have neuroprotective potential on neuroretinal cells via proteins of the mitochondrial apoptosis pathway. PLoS One 2014; 9 (3): e90737.","journal-title":"PLoS One"},{"issue":"3","key":"BFeye2016300_CR46","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.jphs.2014.12.019","volume":"127","author":"C Wilding","year":"2015","unstructured":"Wilding C, Bell K, Funke S, Beck S, Pfeiffer N, Grus FH . GFAP antibodies show protective effect on oxidatively stressed neuroretinal cells via interaction with ERP57. J Pharmacol Sci 2015; 127 (3): 298\u2013304.","journal-title":"J Pharmacol Sci"},{"issue":"2","key":"BFeye2016300_CR47","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1111\/jnc.13765","volume":"139","author":"K Bell","year":"2016","unstructured":"Bell K, Wilding C, Funke S, Perumal N, Beck S, Wolters D et al. Neuroprotective effects of antibodies on retinal ganglion cells in an adolescent retina organ culture. J Neurochem 2016; 139 (2): 256\u2013269.","journal-title":"J Neurochem"},{"issue":"4","key":"BFeye2016300_CR48","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.preteyeres.2006.05.003","volume":"25","author":"A Bringmann","year":"2006","unstructured":"Bringmann A, Pannicke T, Grosche J, Francke M, Wiedemann P, Skatchkov SN et al. Muller cells in the healthy and diseased retina. Prog Retin Eye Res 2006; 25 (4): 397\u2013424.","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"BFeye2016300_CR49","doi-asserted-by":"publisher","first-page":"e57557","DOI":"10.1371\/journal.pone.0057557","volume":"8","author":"OW Gramlich","year":"2013","unstructured":"Gramlich OW, Beck S, von Thun Und Hohenstein-Blaul N, Boehm N, Ziegler A, Vetter JM et al. Enhanced insight into the autoimmune component of glaucoma: IgG autoantibody accumulation and pro-inflammatory conditions in human glaucomatous retina. PLoS One 2013; 8 (2): e57557.","journal-title":"PLoS One"},{"issue":"1","key":"BFeye2016300_CR50","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.bbi.2011.07.241","volume":"26","author":"N Boehm","year":"2012","unstructured":"Boehm N, Wolters D, Thiel U, Lossbrand U, Wiegel N, Pfeiffer N et al. New insights into autoantibody profiles from immune privileged sites in the eye: a glaucoma study. Brain Behav Immun 2012; 26 (1): 96\u2013102.","journal-title":"Brain Behav Immun"}],"container-title":["Eye"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/eye2016300.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2016300","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/eye2016300.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,18]],"date-time":"2023-05-18T17:29:17Z","timestamp":1684430957000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/eye2016300"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,13]]},"references-count":50,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["BFeye2016300"],"URL":"https:\/\/doi.org\/10.1038\/eye.2016.300","relation":{},"ISSN":["0950-222X","1476-5454"],"issn-type":[{"value":"0950-222X","type":"print"},{"value":"1476-5454","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,13]]},"assertion":[{"value":"26 October 2016","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 November 2016","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 January 2017","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no conflict of interest.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}